Congratulations to Niti Goel, MD and her team on their publication in Osteoarthritis and Cartilage. Their latest article explores a newly defined composite measure of symptom progression for knee osteoarthritis, offering valuable insights from a large, randomized study of a potential disease-modifying osteoarthritis drug. This work represents an important step forward in advancing research and treatment for those affected by OA. Kudos to this team for their dedication to improving patient outcomes. https://lnkd.in/dycrcdSY
Fractional Chief Medical Officer|Strategic BioPharma Consultant and Advisor|Board Member
3dThank you! Appreciate that this is being shared. We need to be thinking of ways to get DMOADs across the finish line to approval and use.